hydroxychloroquine has been researched along with Pruritus in 13 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Pruritus: An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Consequently, hydroxychloroquine and topical glucocorticoids therapy were initiated with reported improvement in pruritus, erythema, and scale." | 3.74 | Chronic cutaneous lupus erythematosus in vitiligo. ( Bossenbroek, NM; Johnson, H; Meehan, SA; Pomeranz, MK; Robles, M; Rosenman, K, 2008) |
| "Pruritus was the most common initial symptom reported in both groups, while periungual erythema and Gottron's papules were the most common skin presentations." | 1.39 | A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore. ( Carroll, C; Chan, YH; Jorizzo, J; Kannagra, A; LoSicco, K; Manabat, CG; Ng, P; Tan, A; Yosipovitch, G, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, ME | 1 |
| Harrell, K | 1 |
| McBride, JD | 1 |
| Rowane, M | 1 |
| Schend, J | 1 |
| Patel, J | 1 |
| Hostoffer, R | 1 |
| Subramanyam, C | 1 |
| Wu, H | 1 |
| Puri, P | 1 |
| Chambers, CJ | 1 |
| Sivamani, RK | 1 |
| Tidwell, WJ | 1 |
| Callen, JP | 1 |
| Zschiebsch, K | 1 |
| Fischer, C | 1 |
| Wilken-Schmitz, A | 1 |
| Geisslinger, G | 1 |
| Channon, K | 1 |
| Watschinger, K | 1 |
| Tegeder, I | 1 |
| Johnson, H | 1 |
| Bossenbroek, NM | 1 |
| Rosenman, K | 1 |
| Meehan, SA | 1 |
| Robles, M | 1 |
| Pomeranz, MK | 1 |
| Samrao, A | 1 |
| Chew, AL | 1 |
| Price, V | 1 |
| Lent, M | 1 |
| Jagwani, S | 1 |
| Ward, D | 1 |
| Yosipovitch, G | 1 |
| Tan, A | 1 |
| LoSicco, K | 1 |
| Manabat, CG | 1 |
| Kannagra, A | 1 |
| Carroll, C | 1 |
| Chan, YH | 1 |
| Ng, P | 1 |
| Jorizzo, J | 1 |
| Marzano, AV | 1 |
| Lazzari, R | 1 |
| Polloni, I | 1 |
| Boneschi, V | 1 |
| Crosti, C | 1 |
| Fain, O | 1 |
| Frilay, Y | 1 |
| Sitbon, M | 1 |
| Feton, N | 1 |
| Mathieu, E | 1 |
| Thomas, M | 1 |
| Jiménez-Alonso, J | 1 |
| Tercedor, J | 1 |
| Jáimez, L | 1 |
| García-Lora, E | 1 |
| Holme, SA | 1 |
| Holmes, SC | 1 |
13 other studies available for hydroxychloroquine and Pruritus
| Article | Year |
|---|---|
Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Topics: Arthritis; Dermatitis; Granuloma; Humans; Hydroxychloroquine; Infant; Male; Methotrexate; Mutation; | 2023 |
Rapid desensitization of hydroxychloroquine.
Topics: Anti-Inflammatory Agents; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Hydro | 2020 |
Lichen planopilaris with significant post-inflammatory pigmentary alteration.
Topics: Adult; Dermatologic Agents; Diagnosis, Differential; Humans; Hydroxychloroquine; Hyperpigmentation; | 2021 |
Koebner Phenomenon in Juvenile Dermatomyositis.
Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Creatine Kinase; Dermatologic Ag | 2018 |
Mast cell tetrahydrobiopterin contributes to itch in mice.
Topics: Animals; Biopterins; Calcium; Cell Degranulation; Chronic Pain; Female; Gene Expression; GTP Cyclohy | 2019 |
Chronic cutaneous lupus erythematosus in vitiligo.
Topics: Autoimmunity; Carcinoma, Squamous Cell; Clobetasol; Diabetes Complications; Diagnostic Errors; Drug | 2008 |
Frontal fibrosing alopecia: a clinical review of 36 patients.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Anti-Bacterial Agents; Cohort Studies; Dermatologic Agents | 2010 |
Rowell's syndrome: a distinct clinical entity or a coincidence of diagnoses?
Topics: Administration, Topical; Antibodies, Antinuclear; Antirheumatic Agents; Erythema Multiforme; Female; | 2012 |
A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Asian People; Bone Den | 2013 |
Rosacea-like cutaneous lupus erythematosus: an atypical presentation responding to antimalarials.
Topics: Adult; Aged; Antimalarials; Diagnosis, Differential; Erythema; Female; Humans; Hydroxychloroquine; L | 2013 |
[Pruritus caused by hydroxychloroquine].
Topics: Female; Humans; Hydroxychloroquine; Middle Aged; Pruritus | 1994 |
Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Topics: Adult; Antimalarials; Chloroquine; Data Collection; Female; Humans; Hydroxychloroquine; Lupus Erythe | 1998 |
Hydroxychloroquine-induced pruritus.
Topics: Adult; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Prur | 1999 |